OCM
SGRY icon

Oaktree Capital Management’s Surgery Partners SGRY Stock Holding History

Oaktree Capital Management’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
+862,588
New +$12.1M 0.2% 65

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Oaktree Capital Management's SGRY Position: Q2 2026 in Review

Oaktree Capital Management opened a new position in Surgery Partners (SGRY) in Q2 2026: 862,588 shares worth $14.5M. The stake represents 0.2% of the portfolio and ranks #65 among its holdings.

187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Oaktree Capital Management held 862,588 shares of Surgery Partners worth $14.5M as of Q2 2026.
  • Surgery Partners was a new Oaktree Capital Management position in Q2 2026.
  • Surgery Partners made up 0.2% of Oaktree Capital Management's portfolio in Q2 2026, its #65 holding.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Oaktree Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.